Zydus Cadila gets USFDA approval to market generic schizophrenia drug Perphenazine

Zydus Cadila said it has 284 approvals and has so far filed over 386 abbreviated new drug applications (ANDAs) since the commencement of its filing process in the financial year 2003-2004.

FP Trending April 08, 2020 13:21:11 IST
Zydus Cadila gets USFDA approval to market generic schizophrenia drug Perphenazine

Pharma company Zydus Cadila has said it has received final approval from United States Food and Drug Administration (USFDA) to market generic Perphenazine tablets, used in the treatment of schizophrenia.

The drug is also used for the control of severe nausea and vomiting in adults.

USFDA has given its final nod to the company to market Perphenazine tablets USP in the strengths of 2 mg, 4 mg, 8 mg and 16 mg, Zydus Cadila said in a statement.

Zydus Cadila gets USFDA approval to market generic schizophrenia drug Perphenazine

Representative image. Image source: Pixabay

The USFDA is tasked with promoting public health through the control and supervision of several verticals including over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals and others.

“The drug will be manufactured at the group’s formulation manufacturing facility at Baddi [,” the statement added.

Zydus Cadila said it has 284 approvals and has so far filed over 386 abbreviated new drug applications (ANDAs) since the commencement of its filing process in the financial year 2003-2004.

On Tuesday, the pharma major announced on Twitter that it is producing Hydroxychloroquine, in large quantities to be used in the “treatment of coronavirus.” The company also said that it is working on developing a vaccine which will be a long term solution for COVID-19.

India on Tuesday decided to partially lift the ban on Hydroxychloroquine export, news agency PTI reported quoting officials.

US President Donald Trump had requested Prime Minister Narendra Modi to release the amount of Hydroxychloroquine ordered by the US after India on 25 March banned the export of the drug.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

A new theory asks whether wearing a mask can be a crude COVID-19 ‘vaccine’
science

A new theory asks whether wearing a mask can be a crude COVID-19 ‘vaccine’

The age-old concept of deliberately exposing people to a pathogen to generate a protective immune response was first tried against smallpox paved the way for the rise of modern vaccines.

Officials might have an in-person General Assembly meeting to discuss COVID-19 pandemic
science

Officials might have an in-person General Assembly meeting to discuss COVID-19 pandemic

But several diplomats have said their countries are hesitant to meet so soon — especially in the United States, where the virus that causes the disease continues to spread widely.

Governments neglecting green economies while re-building multi-trillion recovery phase post-COVID-19: OECD report
science

Governments neglecting green economies while re-building multi-trillion recovery phase post-COVID-19: OECD report

Atleast 24 national governments are using post-COVID-19 measures to roll back existing environmental regulations and taxes and increase fossil-fuel intensive infrastructure and electricity.